NCT03077295

Brief Summary

This weight loss study will investigate the impact of diet composition and meal size (large breakfast meals and smaller evening meals) on body weight, energy balance and eating behaviour, by altering calorie (meal) distribution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2016

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 10, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

April 5, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2019

Completed
Last Updated

June 20, 2019

Status Verified

June 1, 2019

Enrollment Period

2 years

First QC Date

December 1, 2016

Last Update Submit

June 19, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Energy Balance

    Chronic influence on energy balance (body weight, kg)

    measured up to day 71 of study

Secondary Outcomes (8)

  • Acute effects on appetite after test meals

    Baseline & week 4 of each treatment

  • Acute effects on biomarkers of health after test meals

    Baseline & week 4 of each treatment

  • Acute effects on gastric emptying after test meals

    Baseline & week 4 of each treatment

  • Resting Metabolic Rate (RMR) before & after test meals

    Baseline & week 4 of each treatment

  • Faecal sample analysis for gut health

    up to 10 weeks

  • +3 more secondary outcomes

Study Arms (2)

High Fibre to High-Protein (HF-HP)

EXPERIMENTAL

* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HF meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HP meals for 4 weeks

Other: High FibreOther: High Protein

High Protein to High-Fibre (HP-HF)

EXPERIMENTAL

* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HP meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HF meals for 4 weeks

Other: High FibreOther: High Protein

Interventions

High fibre/carbohydrate (50% CHO, 35% fat and 15% Protein) with 45% calories at breakfast and 20% evening meal provided and buffet lunch. Total dietary fibre will be at least 30g/d for 2000kcal intake and provided as a mixed soluble and insoluble fibre sources to maintain palatability of the diet (e.g. wheat bran, fava bean, lentil, buckwheat).

Also known as: HF
High Fibre to High-Protein (HF-HP)High Protein to High-Fibre (HP-HF)

• High protein diet (30% protein, 35% fat and 35% CHO) with 45% calories at breakfast and 20% evening meal provided and buffet lunch. Protein will be a mixed meat matrix to include poultry, fish, red meat, prawns, eggs, dairy. Total dietary fibre will be no more than 15g/d for 2000kcal intake.

Also known as: HP
High Fibre to High-Protein (HF-HP)High Protein to High-Fibre (HP-HF)

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI ranging from 27-42 kg/m2;
  • those habitually consuming breakfast (at least 5 times a week).

You may not qualify if:

  • women who are pregnant, planning to be pregnant or breastfeeding
  • subjects with food allergy
  • diagnosis of diabetes, hypertension, renal, hepatic, haematological disease or coronary heart disease
  • having given a pint of blood for transfusion purposes within the last month
  • unsuitable veins for blood sampling
  • inability to understand the participant information sheet
  • inability to speak, read and understand the English language
  • those on any prescription medications (other than oral contraceptives)
  • those on any specific diet regimes
  • those on any weight loss programmes (that may be affecting lifestyle, physical activity and diet).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Rowett Institute

Aberdeen, AB25 2ZD, United Kingdom

Location

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Alexandra Johnstone, PhD

    Senior Research Fellow

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2016

First Posted

March 10, 2017

Study Start

April 5, 2017

Primary Completion

April 5, 2019

Study Completion

April 5, 2019

Last Updated

June 20, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations